期刊文献+

杏仁核点燃癫痫大鼠模型海马组织突触囊泡蛋白2A的表达变化 被引量:3

Expression changes and significance of SV2A in the hippocampus of rats with amygdala-kindling epilepsy models
下载PDF
导出
摘要 目的探讨杏仁核点燃癫痫发生过程中突触囊泡蛋白2A(synaptic vesicle protein 2A,SV2A)在海马组织中表达的动态变化。方法建立杏仁核点燃癫痫大鼠模型,治疗组予左乙拉西坦(levetiracetam,LEV)灌胃,用荧光定量PCR(RealTime-PCR)测定不同时期SV2A mRNA的表达,免疫组织化学方法检测SV2A蛋白的表达。结果 SV2A在1w时表达降低,之后逐渐升高,到8w时达高峰,与对照组比较差异有统计学意义(P<0.05);用药前后相比,除1w组外,2w组、4w组、8w组用相比差异有统计学意义(P<0.05)。结论 SV2A的表达与癫痫的发作有关。 Objective To establish the amygdala-kindling epilepsy rats models,and measure the expression of SV2A to explore the pathogenesis of epilepsy.Methods To establish model of chronic epilepsy by stimulating the amygdala as the epilepsy group,and to perfuse antiepileptic drug of levetiracetam into stomach as the treatment group.The dynamic changes of SV2A were examined by Real-time PCR and immunohistochemistry in the hippocamp tissue.Results Compared with the sham control group,epilepsy group showed decreased the expression after one week,and SV2A in epilepsy eight weeks was higher than control group(P0.05).However,there was significant difference between group after two weeks,four weeks and eight weeks before and after treatment(P0.05).Conclusion The expression of SV2A was closely related to epileptic seizures.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2012年第11期1008-1011,共4页 Journal of Apoplexy and Nervous Diseases
关键词 突触囊泡蛋白2A 海马 慢性癫痫 左乙拉西坦 SV2A Hippocampus Epilepsy Synaptic plasticity
  • 相关文献

参考文献7

  • 1Crowder KM, Gunther JM, Jones TA, et al. Abnormal neurotransmis- sion in mice lacking synaptic vesicle protein 2A (SV2A) [ J ]. Proc Natl Acad Sci USA,1999,96(26) :15268 -15273.
  • 2Schivell AE, Sumiko M, Kensel-Hammes P, et al. SV2A and SV2C contain a unique synaptotagmin-binding site[ J]. Mol Cell Neurosci, 2005,29( 1 ) :56 -64.
  • 3Tan-Cheng JH. Activity-related redistribution of presynaptic proteins at the active zone[ J]. Neuroscience,2006,141:1217 -1224.
  • 4张轶群,李吉,胡玉,田韵,高常青.抗癫痫药物左乙拉西坦[J].中国神经免疫学和神经病学杂志,2010,17(2):145-147. 被引量:10
  • 5Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle pro- teinSV2A is the binding site for the antiepileptic drug levetiracetam [J]. Proc Natl Acad Sci USA,2004,101 (26) :9861 -9866.
  • 6Feng G, Xiao F, Lu Y, et al. Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epi- lepsy[J]. Mol Neurosci. 2009:39 (3) :354 - 359.
  • 7van Vliet EA, Aronica E, Redeker S, et al. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy [ J ]. Epilepsia, 2009,50 ( 3 ) : 422 - 433.

二级参考文献12

  • 1French J. Use of levetiracetam in special populations[J]. Epilepsia, 2001,42:40-43.
  • 2Harden CL, Leppik I. Optimizing therapy of seizures in women who use oral contraceptives[J]. Neurology, 2006,67 : S56-S58.
  • 3Sisodiya SM, Sander JW, Patsalos PN. Carbamazepine toxicity during combination therapy with levetiracetam: A pharmacodynamic interaction[J].Epilepsy Res,2002,48:217-219.
  • 4Kelly K, Stephen LJ, Brodie MJ. Levetiracetam for people with mental retardation and refractory epilepsy[J]. Epilepsy Behav, 2004,5 : 878-883.
  • 5Privitera M. Efficacy of levetiracetam: A review of three pivotal clinical trials[J].Epilepsia,2001,42 : 31-35.
  • 6Leppik IE, Biton V, Sander JW, et al. Levetiracetam and par tial seizure subtypes: Pooled data from three randomized, pla eebo-eontrolled trials[J].Epilepsia, 2003,44 : 1585-1587.
  • 7Morrell MJ, Leppik I, French J, et al. The KEEPER trial: Levetiracetam adjunctive treatment of partial-onset seizures in an open-label community based study[J]. Epilepsy Res,2003, 54:153-161.
  • 8Brodie MJ, Perucca E, Ryvlin P, et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy[J].Neurology, 2007, 68(6):402-408.
  • 9Verdru P, Wajgt A, Schi,emann Delgado J, et al. Efficacy and safety of levetiracetam 3000 mg/d as adjunctive treatment in adolescents and adults suffering from idiopathic generalized ep ilepsy with myoclonic seizures[J]. Epilepsia, 2005,46:56.
  • 10Grtinewald R. Levetiracetam in the treatment of idiopathic generalized epilepsies [J]. Epilepsia, 2005,46: 154-160.

共引文献9

同被引文献36

  • 1姚鹏程,叶恭银.网格蛋白介导的内吞作用机制[J].生命科学研究,2003,7(S1):22-25. 被引量:10
  • 2龚云,王学峰,汪建华,朱曦,晏勇,奕国明,王玉平,张国君,李云林,张建国,杨辉.难治性癫癎患者脑组织突触囊泡回收相关蛋白的表达[J].中华神经科杂志,2006,39(3):155-158. 被引量:5
  • 3王乃东,赵永波,陈英辉,呙登俊,张芳,岳旺.低频脑深部电刺激对大鼠杏仁核点燃的抑制作用及其相关机制探讨[J].中华物理医学与康复杂志,2007,29(5):296-299. 被引量:5
  • 4Cui H, Sakamoto H, Higashi S, et al. Effects of single-prolonged stress on neurons and their afferent inputs in the amygdala[J]. Neuroscience, 2008, 152(3): 703-712. DOI:10.1016/j.neuroscience.2007.12.028.
  • 5Harding AJ, Stimson E, Henderson JM, et al. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease[J]. Brain, 2002, 125(Pt 11): 2431-2445.
  • 6Ding J, Han F, Shi Y. Single-prolonged stressinduces apoptosisin the amygdalein a rat model of posttraumatic stressdisorder[J]. J Psychiatr Res, 2010, 44(1): 48-55. DOI:10.1016/j.jpsychires.2009.06.001.
  • 7董玉琳, 李云庆. 神经病理性痛状态下中央杏仁核囊状部突触结构可塑性变化[C]//2012年年会论文文摘汇编. 北京: 中国解剖学会, 2012: 34.
  • 8Fusar-Poli P, Placentino A, Carletti F, et al. Functional Atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies[J]. J Psychiatry Neurosci, 2009, 34(6): 418-432.
  • 9Lorenzetti V, Allen NB, Whittle S, et al. Amygdala volumes in a sample of current depressed and remitted depressed patients and healthy controls[J]. J Affect Disord, 2010, 120(1/3): 112-119. DOI:10.1016/j.jad.2009.04.021.
  • 10Wang HB, Ma N, Yu YQ, et al. Is the contribution of the amygdala to the sex- and enhancement-related effects of emotional memory time-dependent?[J]. Neurobiol Learn Mem, 2010, 93(1): 1-7. DOI:10.1016/j.nlm.2009.07.009.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部